US FDA Credibility: Surprisingly Strong, Despite Everything
Executive Summary
A Senate Health Committee update hearing on the COVID-19 federal response was noteworthy primarily for demonstrating that FDA Commissioner Stephen Hahn appears to have salvaged the agency’s position as a voice of credibility with a key political constituency – at least for now.
You may also be interested in...
Hahn Says COVID Vaccine Review Could Take Months As Trump Floats Rejecting New EUA Guidance
Commissioner’s comments were yet another sign that US FDA won’t clear a vaccine ahead of the election, but hours later the president suggests the White House may decline to clear the agency’s new guidance on emergency use authorization standards for COVID-19 vaccines, raising new concerns about political interference in any decisions.
Gottlieb vs Azar vs Califf vs Gottlieb: The Public Fight Over How The US FDA Should Operate
Yes, Gottlieb’s in there twice; things get complicated when an agency starts to lose credibility.
US FDA Has Done Over 200 ‘Mission Critical’ Inspections During COVID
For now, agency appears to be in early stages of testing alternative inspection models beyond the flexibility it has been applying throughout the pandemic.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: